Ligne de temps
Bruno Charbit
Ingénieur(e) de Recherche
14 févr. 2024
01 févr. 2024
15 nov. 2023
news
New publication – Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses
Lire plus25 nov. 2022
publication
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.
Lire plus15 nov. 2022
publication
Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort.
Lire plus28 juin 2022
publication
Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation.
Lire plus20 juin 2022
publication
Variability of Primary Sjögren’s Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ Locus.
Lire plus28 mars 2022
news
New publication – Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency
Lire plus09 mars 2022
publication
Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes.
Lire plus14 févr. 2022
publication
Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency.
Lire plus01 janv. 2022
publication
Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses.
Lire plus01 déc. 2021
publication
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.
Lire plus17 nov. 2021
publication
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
Lire plus01 sept. 2021
publication
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Lire plus18 août 2021
01 août 2021
publication
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Lire plus17 juil. 2021
04 juin 2021
publication
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.
Lire plus04 janv. 2021
publication
Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers.
Lire plus10 déc. 2020
publication
Associations between untargeted plasma metabolomic signatures and gut microbiota composition in the Milieu Intérieur population of healthy adults.
Lire plus16 oct. 2020
publication
Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis Infection.
Lire plus13 juil. 2020
publication
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
Lire plus01 juin 2020
publication
Antibody-coated microbiota in nasopharynx of healthy individuals and IVIg-treated patients with hypogammaglobulinemia.
Lire plus27 mai 2020
publication
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.
Lire plus10 avr. 2020
23 sept. 2019
10 juil. 2019
publication
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment
Lire plus05 sept. 2018
publication
Human thymopoiesis is influenced by a common genetic variant within the TCRA-TCRD locus.
Lire plus27 juil. 2018
publication
Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines.
Lire plus16 janv. 2018
publication
Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges.
Lire plus02 juil. 2015